IVD Medical Holding (HKSE:01931) 3-Year EBITDA Growth Rate : 7.40% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding 3-Year EBITDA Growth Rate?

IVD Medical Holding's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.15.

During the past 12 months, IVD Medical Holding's average EBITDA Per Share Growth Rate was 11.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 7.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of IVD Medical Holding was 74.60% per year. The lowest was -5.90% per year. And the median was 27.00% per year.

Competitive Comparison of IVD Medical Holding's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, IVD Medical Holding's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IVD Medical Holding's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where IVD Medical Holding's 3-Year EBITDA Growth Rate falls into.

IVD Medical Holding 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

IVD Medical Holding (HKSE:01931) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

IVD Medical Holding 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

IVD Medical Holding (HKSE:01931) Headlines

No Headlines